Should You Invest In Centrica PLC (ADR) (CPYYY), Giga-tronics, Incorporated (GIGA), and ImmunoCellular Therapeutics Ltd (IMUC)?
New York, NY – GDP INSIDER – 12/10/2014.
This article discusses three companies: Centrica PLC (ADR)(OTCMKTS:CPYYY), Giga-tronics, Incorporated(NASDAQ:GIGA), and ImmunoCellular Therapeutics Ltd(NYSEMKT:IMUC)
Centrica PLC (ADR)(OTCMKTS:CPYYY) traded for a new 52 week low of $17.44 yesterday. The stock had previously traded for a one-year high of $23.57. Centrica PLC had a trading volume of 0.28 million yesterday, which is 0.2 million higher than its three month average volume of 0.08 million. The company has a market capitalization of $22.04 billion, and a price to earnings ratio (TTM) of $21..48, and an earnings per share (TTM) of $0.81.
Giga-tronics, Incorporated(NASDAQ:GIGA) has a beta of –0.15, which indicates that the stock has an inverse relationship with the market. The company also has an earnings per share (TTM) of $–0.46, which could scare off potential investors. Giga-tronics Inc. had a trading volume of 0.11 million yesterday, which is 0.05 million higher than its three month average volume of 0.06 million. The company has a market capitalization of $8.59 million.
ImmunoCellular Therapeutics Ltd(NYSEMKT:IMUC) has traded within a range of $0.53 to $2.88 over the past 52 weeks, yet finished yesterday’s trading at a closing price of $0.79 after a 1.65% loss of one cent. The company does have a one-year target estimate of $3.50, however, which indicates that the stock could see its value rise in the near future. ImmunoCellular Therapeutics has a three month average volume of 0.51 million, a market capitalization of $49.66 million, and a beta of 1.76.
HotStockGains.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.
Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.
Disclosure: HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.